Trial intelligence / Profile preview

Pregabalin for radiotherapy-related neuropathic pain

NCT01869569Phase 2Completed

Sponsor
Sun Yat-sen Memorial Hospital
Start
Feb 2013
Primary completion
Oct 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in neuropathic pain comparing Pregabalin with Placebo (2 arms). Primary endpoint: Numeric Rating Scale at 16 weeks. Started Feb 2013; status: completed.

02

Drugs

pregabalin
03

Conditions

neuropathic pain

Beyond the preview

Go deeper on NCT01869569.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01869569.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call